For patients with AFP≥400 μg/L for more than 1 month, ≥200 μg/L for 2 months, or a gradually increased and stabilized AFP level but without pregnancy, gonadal embryoma, or active liver disease, HCC should be highly suspected. This evidence concerns the gene AFP and liver disorder.